Advanced cross-linked hyaluronic acid gel with 20mg/ml concentration and 3mg/ml lidocaine. Manufactured using Hugel Pharma’s proprietary low-temperature cross-linking technology with <0.5ppm BDDE residue and <0.03 EU/ml endotoxin levels. FDA-equivalent certified for dermal rejuvenation and contouring.

CLINICAL ADVANTAGES

CROSS-LINKING INNOVATION

CLINICAL PACKAGE

INJECTION PROTOCOL

*For certified medical practitioners only. Individual results may vary based on injection technique and tissue characteristics. Not recommended for patients with history of severe allergic reactions. Contains lidocaine hydrochloride – verify patient tolerance prior to administration.